“Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal”, TMTJ, vol. 4, no. 1, pp. 28–36, Apr. 2025, doi: 10.5281/zenodo.22649336.